Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- dor torácica
- dispneia ao esforço
- hipotensão
- estertores
- B3 em galope
- hipertensão
- náuseas
- diaforese
- taquicardia
- dispepsia
Other diagnostic factors
- fraqueza unilateral, dormência e/ou parestesia
- cefaleia
- claudicação intermitente
- sopros
- afasia
- perda hemissensitiva
- paralisia de nervo craniano
- convulsões
- vertigem
- dor nos membros em repouso
- pulsos de membro inferior diminuídos/ausentes
- úlceras ou gangrena
- edema periférico
- pele macia e brilhante com queda de cabelos
- palidez
Risk factors
- tabagismo
- hipertensão
- dislipidemia
- controle glicêmico inadequado
- sedentarismo
- sobrepeso e obesidade
- albuminúria
- doença renal crônica (DRC)
- proteína C-reativa elevada
- história familiar de DCV
- sexo feminino
- diabetes gestacional
- transtorno mental
- doença hepática esteatótica associada a disfunção metabólica (anteriormente doença hepática gordurosa não alcoólica)
- fibrilação atrial
Diagnostic investigations
1st investigations to order
- HbA1c
- perfil lipídico
Investigations to consider
- Peptídeo natriurético do tipo B (PNB)/fragmento N-terminal do peptídeo natriurético do tipo B (NT-proPNB)
- ecocardiografia transtorácica com Doppler
- eletrocardiografia de esforço
- teste ergométrico (estresse) com imagem
- teste farmacológico (estresse) com imagem
- RNM cardíaca ou RNM cardíaca sob estresse
- índice tornozelo-braquial (ITB)
- angiografia coronariana por tomografia computadorizada
- TC com escore de cálcio coronário
- angiografia coronariana invasiva
- tomografia computadorizada (TC) de crânio sem contraste
- ressonância nuclear magnética (RNM) cranioencefálica
- ultrassonografia duplex das artérias carótidas
- proteína C-reativa
- radiografia torácica
Treatment algorithm
infarto agudo do miocárdio ou angina instável
doença arterial coronariana altamente significativa: sem infarto agudo do miocárdio ou angina instável
doença cardiovascular diabética: estável e/ou após intervenção
Contributors
Authors
Mohamed Al-Kazaz, MD
Assistant Professor of Medicine (Cardiology)
Section Chief, General Cardiology
Division of Cardiology, Department of Medicine
Northwestern University Feinberg School of Medicine
Bluhm Cardiovascular Institute
Northwestern Memorial Hospital
Chicago
IL
Disclosures
MA is a speaker for Kiniksa Pharmaceuticals in relation to pericarditis/rilonacept.
Acknowledgements
Dr Mohamed Al-Kazaz would like to gratefully acknowledge Dr Alexander Meyer, Dr Laura Davidson, Dr Charles Davidson, and Dr Leonard E. Egede, the previous contributors to this topic, and would like to gratefully acknowledge the review by Dr Shreenidhi Venuraju, MB BS, MRCP, Wellington Hospital South, UK.
Disclosures
AM, LD, CD, and LE declare that they have no competing interests. LEE is an author of a number of references cited in this topic. SV not disclosed.
Peer reviewers
Irfan Moinuddin, MD
Assistant Professor
Chicago Medical School
Rosalind Franklin University
Lombard
IL
Disclosures
IM declares that he has no competing interests.
David Leehey, MD
Medical Director
Hines VA Hospital
Hines
IL
Disclosures
DL declares that he has no competing interests.
References
Key articles
Marx N, Federici M, Schütt K, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043-140.Full text Abstract
American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care 2024 Jan 1;47(suppl 1):S1-321.Full text
Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022 Mar;145(9):e722-59.Full text Abstract
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-248.Full text Abstract
Writing Committee Members; Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022 Jan 18;79(2):e21-129.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Angina instável
- Infarto do miocárdio com supradesnivelamento do segmento ST (IAMCSST)
- Infarto do miocárdio sem supradesnivelamento do segmento ST (IAMSSST)
More DifferentialsGuidelines
- 2024 guideline for the primary prevention of stroke
- Newer pharmacological treatments in adults with type 2 diabetes
More GuidelinesPatient information
Diabetes do tipo 2: devo tomar insulina?
Diabetes: o que posso fazer para me manter saudável?
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer